Structural and functional evolution of IL-1 targeting: From systemic neutralization to bioengineered nanotherapies. [PDF]
Yang L, Chen G, Lyu Z.
europepmc +1 more source
An IL-1, IL-17, and IL-22 cytokine circuit controls vulvovaginal candidiasis independently of estrogen. [PDF]
Coleman BM +14 more
europepmc +1 more source
IL-1 delineates squalene-based adjuvant efficacy and reactogenicity in a cell-type-specific manner. [PDF]
Yoshioka Y +19 more
europepmc +1 more source
Early IL-1 inhibition and long-term remission in childhood-onset Still's disease: a real-world cohort study. [PDF]
Bozkaya Yücel B +3 more
europepmc +1 more source
Pro-Inflammatory Synergy Between IL-17, IL-1 and Hyperuricemia in Psoriatic Arthritis: Clinical Implications of a Pilot Study. [PDF]
Suiu LI +5 more
europepmc +1 more source
IL-1-mediated vitreous inflammation as an early indicator of retinal ganglion cell loss following acute optic nerve injury. [PDF]
Chang S +10 more
europepmc +1 more source
The effect of IL-1 blockers on exertional leg pain in familial Mediterranean fever patients: an exploratory study. [PDF]
Druyan A +4 more
europepmc +1 more source
IL-1 signaling and inflammasomes in acute myeloid leukemia: mechanisms and therapeutic opportunities. [PDF]
Mortellaro A, Mastaglio S, Muzio M.
europepmc +1 more source
Age- and Genotype-Associated Specific Expression of IL-1 and TNF Receptors on Immunocompetent Cells. [PDF]
Zhukova J +5 more
europepmc +1 more source
Early IL-1 Inhibition in Still's Disease: A Window of Opportunity for Improving Outcomes. [PDF]
Bindoli S +5 more
europepmc +1 more source

